Open access · CC-BY
via OpenAlex
Biomarkers of sepsis: time for a reappraisal
Charalampos Pierrakos, Dimitrios Velissaris, Max Bisdorff, John C. Marshall, Jean‐Louis Vincent
Critical Care · 2020 · ▲ 710 citations
Abstract
INTRODUCTION: Sepsis biomarkers can have important diagnostic, therapeutic, and prognostic functions. In a previous review, we identified 3370 references reporting on 178 different biomarkers related to sepsis. In the present review, we evaluate the progress in the research of sepsis biomarkers. METHODS: Using the same methodology as in our previous review, we searched the PubMed database from 2009 until September 2019 using the terms "Biomarker" AND "Sepsis." There were no restrictions by age or language, and all studies, clinical and experimental, were included. RESULTS: We retrieved a total of 5367 new references since our previous review. We identified 258 biomarkers, 80 of which were new compared to our previous list. The majority of biomarkers have been evaluated in fewer than 5 studies, with 81 (31%) being assessed in just a single study. Apart from studies of C-reactive protein (CRP) or procalcitonin (PCT), only 26 biomarkers have been assessed in clinical studies with more than 300 participants. Forty biomarkers have been compared to PCT and/or CRP for their diagnostic value; 9 were shown to have a better diagnostic value for sepsis than either or both of these biomarkers. Forty-four biomarkers have been evaluated for a role in answering a specific clinical question rather than for their general diagnostic or prognostic properties in sepsis. CONCLUSIONS: The number of biomarkers being identified is still increasing although at a slower rate than in the past. Most of the biomarkers have not been well-studied; in particular, the clinical role of these biomarkers needs to be better evaluated.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1186/s13054-020-02993-5
- Canonical
- link ↗
- Fetched
- 2026-07-28 MST
Cite this
APA
Pierrakos, C., Velissaris, D., Bisdorff, M., Marshall, J.C., & Vincent, J. (2020). Biomarkers of sepsis: time for a reappraisal. <em>Critical Care</em>. https://doi.org/10.1186/s13054-020-02993-5
Vancouver
Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent J. Biomarkers of sepsis: time for a reappraisal. Critical Care. 2020. doi:10.1186/s13054-020-02993-5.
BibTeX
@article{charalampos2020Biomar,
title = {Biomarkers of sepsis: time for a reappraisal},
author = {Charalampos Pierrakos and Dimitrios Velissaris and Max Bisdorff and John C. Marshall and Jean‐Louis Vincent},
journal = {Critical Care},
year = {2020},
doi = {10.1186/s13054-020-02993-5},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Aaron Ritter, MD 2018
Open access · US-GOV
The Relationship Between Neuropsychological Testing and MRI, PET and Blood Biomarkers in Neurodegenerative Disease (COBRE - Project 1): AIM 2
Neurology 2016
Open access · OA
Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia
Journal of Multidisciplinary Healthcare 2023
Open access · CC-BY
The Contribution of Procalcitonin, C-Reactive Protein and Interleukin-6 in the Diagnosis and Prognosis of Surgical Sepsis: An Observational and Statistical Study
Ageing Research Reviews 2018
Open access · CC-BY
Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases
Critical Care 2010
Open access · CC-BY
Sepsis biomarkers: a review
Frontiers in Physiology 2015
Open access · CC-BY